ESTIMATING MARGINAL RETURNS TO MEDICAL CARE: EVIDENCE FROM AT-RISK NEWBORNS

Douglas Almond1, Joseph J Doyle, Amanda E Kowalski

  • 1Columbia University and NBER, MIT and NBER, Yale University and NBER, Harvard University.

The Quarterly Journal of Economics
|July 17, 2010
PubMed

Insights

Medical spending near the 1500-gram threshold significantly reduces newborn mortality. This study estimates the cost of saving a statistical life for very low birth weight infants, providing crucial data for healthcare policy decisions.

Area of Science:

  • Health Economics
  • Perinatal Medicine
  • Biostatistics

Background:

  • Assessing the cost-effectiveness of medical interventions is crucial for healthcare policy.
  • Diagnostic thresholds can create natural experiments for evaluating medical spending impacts.
  • The very low birth weight (VLBW) designation, often around 1500 grams, triggers intensive medical care.

Purpose of the Study:

  • To estimate the marginal returns of medical spending on newborn health outcomes.
  • To determine the cost of saving a statistical life (CSL) for infants near the VLBW threshold.
  • To utilize regression discontinuity design (RDD) to analyze the impact of medical inputs.

Main Methods:

  • Employed RDD to compare outcomes for newborns just below and above the 1500-gram birth weight threshold.
  • Utilized US birth census data (1983-2002) for mortality analysis.
  • Analyzed hospital discharge records (1991-2006) for medical input and cost data.

Main Results:

  • Newborns just below 1500 grams had significantly lower one-year mortality rates (approx. 1 percentage point reduction).
  • Infants below the 1500-gram threshold experienced discontinuously higher medical costs (approx. $4,000 increase).
  • Estimated cost of saving a statistical life for VLBW infants near 1500 grams is approximately $550,000 (2006 dollars).

Conclusions:

  • The marginal benefits of medical spending for VLBW infants appear to exceed their costs.
  • The 1500-gram threshold effectively identifies infants who benefit significantly from intensive medical care.
  • Findings support the value of targeted medical interventions for high-risk newborns.

Related Concept Videos

Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...